Hazlehurst Lori A
Department of Interdisciplinary Oncology, Experimental Therapeutics and Drug Discovery Programs, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
Methods Mol Biol. 2009;523:169-76. doi: 10.1007/978-1-59745-190-1_12.
The comet assay is a simple gel electrophoresis method for visualizing and quantifying DNA damage. The comet assay is sensitive and reproducible and can be used to detect single-strand DNA breaks, double-strand DNA breaks, protein-associated DNA strand breaks and DNA crosslinks. The comet assay uses fluorescent DNA-binding dyes to detect both damaged DNA that resides in the tail region and undamaged DNA that is retained in the head region following gel electrophoresis. This assay is a single cell-based assay and thus is highly adaptable for measuring DNA damage in clinical samples. Furthermore, unlike other assays the detection of DNA damage is not dependent on the random incorporation of radiolabeled nucleotides. Again this can be problematic with clinical samples as proliferation rates are often slow and culturing of primary patient specimens for 48 h required to randomly label DNA is often not possible. In this chapter we will outline the comet assay for the detection of DNA damage induced by topoisomerase II inhibitors, cross-linking agents and gamma radiation.
彗星试验是一种用于可视化和定量DNA损伤的简单凝胶电泳方法。彗星试验灵敏且可重复,可用于检测单链DNA断裂、双链DNA断裂、蛋白质相关的DNA链断裂和DNA交联。彗星试验使用荧光DNA结合染料来检测凝胶电泳后位于尾部区域的受损DNA和保留在头部区域的未受损DNA。该试验是基于单细胞的试验,因此非常适合测量临床样本中的DNA损伤。此外,与其他试验不同,DNA损伤的检测不依赖于放射性标记核苷酸的随机掺入。同样,这对于临床样本可能会有问题,因为增殖率通常很慢,而且通常不可能将原发性患者标本培养48小时以随机标记DNA。在本章中,我们将概述用于检测拓扑异构酶II抑制剂、交联剂和γ辐射诱导的DNA损伤的彗星试验。